Your search returned 16 results.

Results
	1.	Mouse 4T1 breast tumor model. [electronic resource] by Pulaski, B A Ostrand-Rosenberg, S Producer: 20080519 In: Current protocols in immunology vol. Chapter 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Reduction of established spontaneous mammary carcinoma metastases following immunotherapy with major histocompatibility complex class II and B7.1 cell-based tumor vaccines. [electronic resource] by Pulaski, B A Ostrand-Rosenberg, S Producer: 19980416 In: Cancer research vol. 58 Availability: No items available. Save to lists Add to cart (remove)
	3.	Assembly of 60S ribosomal subunits is perturbed in temperature-sensitive yeast mutants defective in ribosomal protein L16. [electronic resource] by Moritz, M Pulaski, B A Woolford, J L Producer: 19911114 In: Molecular and cellular biology vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4.	Tumor antigen presentation: changing the rules. [electronic resource] by Armstrong, T D Pulaski, B A Ostrand-Rosenberg, S Producer: 19980506 In: Cancer immunology, immunotherapy : CII vol. 46 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	5.	Immunotherapy with vaccines combining MHC class II/CD80+ tumor cells with interleukin-12 reduces established metastatic disease and stimulates immune effectors and monokine induced by interferon gamma. [electronic resource] by Pulaski, B A Clements, V K Pipeling, M R Ostrand-Rosenberg, S Producer: 20000509 In: Cancer immunology, immunotherapy : CII vol. 49 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	6.	Immunotherapy of established tumor with MHC class II and B7.1 cell-based tumor vaccines. [electronic resource] by Ostrand-Rosenberg, S Pulaski, B A Armstrong, T D Clements, V K Producer: 19990318 In: Advances in experimental medicine and biology vol. 451 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	7.	Cooperativity of Staphylococcal aureus enterotoxin B superantigen, major histocompatibility complex class II, and CD80 for immunotherapy of advanced spontaneous metastases in a clinically relevant postoperative mouse breast cancer model. [electronic resource] by Pulaski, B A Terman, D S Khan, S Muller, E Ostrand-Rosenberg, S Producer: 20000613 In: Cancer research vol. 60 Availability: No items available. Save to lists Add to cart (remove)
	8.	Interleukin-3 inhibits the generation of nonspecific killers by interleukin-2. [electronic resource] by McAdam, A J Yeh, K Y Pulaski, B A Frelinger, J G Lord, E M Producer: 19940215 In: Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	9.	Cell-based vaccines for the stimulation of immunity to metastatic cancers. [electronic resource] by Ostrand-Rosenberg, S Pulaski, B A Clements, V K Qi, L Pipeling, M R Hanyok, L A Producer: 19991222 In: Immunological reviews vol. 170 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	10.	Interleukin 3 enhances development of tumor-reactive cytotoxic cells by a CD4-dependent mechanism. [electronic resource] by Pulaski, B A McAdam, A J Hutter, E K Biggar, S Lord, E M Frelinger, J G Producer: 19930601 In: Cancer research vol. 53 Availability: No items available. Save to lists Add to cart (remove)
	11.	IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes. [electronic resource] by Yeh, K Y McAdam, A J Pulaski, B A Shastri, N Frelinger, J G Lord, E M Producer: 19980720 In: Journal of immunology (Baltimore, Md. : 1950) vol. 160 Availability: No items available. Save to lists Add to cart (remove)
	12.	Synergistic effects of co-expression of the TH1 cytokines IL-2 and IFN-gamma on generation of murine tumor-reactive cytotoxic cells. [electronic resource] by McAdam, A J Pulaski, B A Harkins, S S Hutter, E K Lord, E M Frelinger, J G Producer: 19950630 In: International journal of cancer vol. 61 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	13.	Analysis of the effect of cytokines (interleukins 2, 3, 4, and 6, granulocyte-monocyte colony-stimulating factor, and interferon-gamma) on generation of primary cytotoxic T lymphocytes against a weakly immunogenic tumor. [electronic resource] by McAdam, A J Pulaski, B A Storozynsky, E Yeh, K Y Sickel, J Z Frelinger, J G Lord, E M Producer: 19951031 In: Cellular immunology vol. 165 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	14.	Interleukin 3 enhances cytotoxic T lymphocyte development and class I major histocompatibility complex "re-presentation" of exogenous antigen by tumor-infiltrating antigen-presenting cells. [electronic resource] by Pulaski, B A Yeh, K Y Shastri, N Maltby, K M Penney, D P Lord, E M Frelinger, J G Producer: 19960618 In: Proceedings of the National Academy of Sciences of the United States of America vol. 93 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	15.	Transfection of transforming growth factor-beta producing tumor EMT6 with interleukin-2 elicits tumor rejection and tumor reactive cytotoxic T-lymphocytes. [electronic resource] by McAdam, A J Felcher, A Woods, M L Pulaski, B A Hutter, E K Frelinger, J G Lord, E M Producer: 19940817 In: Journal of immunotherapy with emphasis on tumor immunology : official journal of the Society for Biological Therapy vol. 15 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	16.	B7-1 enhances natural killer cell-mediated cytotoxicity and inhibits tumor growth of a poorly immunogenic murine carcinoma. [electronic resource] by Yeh, K Y Pulaski, B A Woods, M L McAdam, A J Gaspari, A A Frelinger, J G Lord, E M Producer: 19951031 In: Cellular immunology vol. 165 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)